Reduced Glutathione

Reduced Glutathione Peptide Vials

Reduced Glutathione Vials represent a specialized research product designed exclusively for laboratory investigations and scientific studies. These vials are an essential molecule notorious for its antioxidant properties and its vital role in cellular signaling.

When reconstituting lyophilized peptides above 50mg, a higher volume of bacteriostatic water may be needed. Using too little can prevent complete dissolution, leaving some powder undissolved.

Key Characteristics

The vials house a concentrated and purified form of reduced glutathione, providing researchers with a controlled environment for exploring the potential benefits and applications of this essential tripeptide.

Research Applications

Reduced Glutathione Vials are crucial in studies exploring the diverse applications of reduced glutathione in various physiological contexts.

Research Benefits

Reduced Glutathione and Diabetes

Research studies have indicated potential benefits of reduced glutathione in the context of diabetes. Investigations aim to understand the mechanisms by which reduced glutathione may help regulate glycemic control, with implications for managing diabetes.

Reduced Glutathione and Liver Health

Preliminary research suggests a positive association between reduced glutathione and liver health. Studies focus on elucidating how this tripeptide may contribute to liver function and its potential applications in promoting hepatic well-being.

Reduced Glutathione and Respiratory Disease Symptoms

Exploratory studies have suggested a possible link between reduced glutathione and the alleviation of respiratory disease symptoms. Research aims to uncover the mechanisms through which reduced glutathione may impact respiratory health and its potential therapeutic implications.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our content is designed for research purposes and is not a substitute for professional analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Sekhar, R. V., McKay, S. V., Patel, S. G., Guthikonda, A. P., Reddy, V. T., Balasubramanyam, A., & Jahoor, F. (2011). Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care, 34(1), 162–167.[Read More]
2. Dentico, P., Volpe, A., Buongiorno, R., Grattagliano, I., Altomare, E., Tantimonaco, G., Scotto, G., Sacco, R., & Schiraldi, O. (1995). Il glutatione nella terapia delle epatopatie croniche steatosiche [Glutathione in the treatment of chronic fatty liver diseases]. Recenti Progressi in Medicina, 86(7-8), 290–293. PMID: 7569285. [Read More]
3. Kerksick, C., & Willoughby, D. (2005). The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. Journal of the International Society of Sports Nutrition, 2(2), 38–44. [Read More]